CY1116049T1 - PRINTER POLYPeptides for the transport of a compound through the blood-brain barrier - Google Patents

PRINTER POLYPeptides for the transport of a compound through the blood-brain barrier

Info

Publication number
CY1116049T1
CY1116049T1 CY20151100011T CY151100011T CY1116049T1 CY 1116049 T1 CY1116049 T1 CY 1116049T1 CY 20151100011 T CY20151100011 T CY 20151100011T CY 151100011 T CY151100011 T CY 151100011T CY 1116049 T1 CY1116049 T1 CY 1116049T1
Authority
CY
Cyprus
Prior art keywords
polypeptides
transport
compound
brain barrier
blood
Prior art date
Application number
CY20151100011T
Other languages
Greek (el)
Inventor
Richard Beliveau
Michel Demeule
Christian Che
Anthony Regina
Original Assignee
Angiochem Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11000946.1A external-priority patent/EP2360258B1/en
Application filed by Angiochem Inc. filed Critical Angiochem Inc.
Publication of CY1116049T1 publication Critical patent/CY1116049T1/en

Links

Abstract

Η παρούσα εφεύρεση σχετίζεται με βελτιώσεις στον τομέα της χορήγησης φαρμάκων. Ειδικότερα, η εφεύρεση σχετίζεται με πολυπεπτίδια που προέρχονται από απροτινίνη και από ανάλογα απροτινίνης, καθώς και συζεύγματα και φαρμακευτικές συνθέσεις που περιέχουν αυτά τα πολυπεπτίδια ή συζεύγματα. Η παρούσα εφεύρεση σχετίζεται επίσης με την χρήση αυτών των πολυπεπτιδίων στην μεταφορά μιας ένωσης ή φαρμάκου μέσα στον αιματοεγκεφαλικό φραγμό ενός θηλαστικού και στην θεραπεία και διάγνωση νευρολογικών νόσων.The present invention relates to improvements in the field of drug administration. In particular, the invention relates to aprotinin and aprotinin-derived polypeptides, as well as conjugates and pharmaceutical compositions containing these polypeptides or conjugates. The present invention also relates to the use of these polypeptides in the transport of a compound or drug into a mammalian blood-brain barrier and in the treatment and diagnosis of neurological diseases.

CY20151100011T 2005-02-18 2015-01-07 PRINTER POLYPeptides for the transport of a compound through the blood-brain barrier CY1116049T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65392805A 2005-02-18 2005-02-18
EP11000946.1A EP2360258B1 (en) 2005-02-18 2005-07-21 Aprotinin polypeptides for transporting a compound across the blood-brain barrier

Publications (1)

Publication Number Publication Date
CY1116049T1 true CY1116049T1 (en) 2017-01-25

Family

ID=58457260

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100011T CY1116049T1 (en) 2005-02-18 2015-01-07 PRINTER POLYPeptides for the transport of a compound through the blood-brain barrier

Country Status (1)

Country Link
CY (1) CY1116049T1 (en)

Similar Documents

Publication Publication Date Title
BRPI0520032A2 (en) molecules to carry a compound through the blood brain barrier
CY1122226T1 (en) PRODRUGS CONTAINING AN EXEDINE CONJUGATE
CY1114941T1 (en) CYCLODEX-based MULTILATERAL BASED FOR ADMINISTRATION OF THERAPEUTICALLY COMMITTED MEDICINES
CY1112278T1 (en) Cytotoxic agents containing new tomomycin derivatives and their therapeutic use
CY1124690T1 (en) POSACONAZOLE INTRAVENOUS SOLUTION PREPARATIONS STABILIZED WITH BETA-SUBSTITUTED CYCLODEXTRIN
CY1117576T1 (en) NUCLEOTIC PRODUCTS
CY1118731T1 (en) ALVIGLUTIDIS PHARMACEUTICAL COMPOSITIONS
CY1118232T1 (en) PHARMACEUTICAL PROPERTIES OF PHARMACEUTICAL PROPERTIES
CY1113258T1 (en) SHEET-VINYLSTEIN COMPLEX AS A MEDICINE
CY1116688T1 (en) MODIFICATIONS OF PHARMACEUTICAL PROPERTIES OF THERAPEUTIC PRODUCTS
NZ745069A (en) Pyrrolobenzodiazepines and conjugates thereof
CY1111065T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN OMEGA-CARBOXYRYL SUBSTITUTED DIFFINYL URINARY FOR CANCER TREATMENT
CY1117470T1 (en) SOLID DOSAGE PREPARATIONS WITH IMPROVED ANIMAL ADJUSTMENT
CY1114215T1 (en) PHARMACEUTICAL SOLUTIONS FOR SOLID PRESSURE INHIBITORS
EP1988910A4 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
CY1111797T1 (en) LOCAL PHARMACEUTICAL FORM FOR IVERMECTIN FOR DERMATOLOGICAL TREATMENT
CY1113003T1 (en) LAQUINIMOD STABLE PREPARATIONS
CY1115414T1 (en) Substituted 1-3-bisphenylpropane derivatives, preparations and their uses
EP1496076A4 (en) Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound
MX2021005134A (en) Cytostatic conjugates with integrin ligands.
CY1114140T1 (en) 4-PYRIDINONE COMPONENTS AND THEIR USE FOR CANCER
CY1111442T1 (en) Piperidine compounds and their uses
MX2010005813A (en) Oligomer-tricyclic conjugates.
BRPI0509067A (en) oral matrix formulations comprising licarbazepine
PL1987063T3 (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition